Filing Details
- Accession Number:
- 0001140361-11-012560
- Form Type:
- 5
- Zero Holdings:
- No
- Publication Time:
- 2011-02-28 14:25:08
- Reporting Period:
- 2010-12-31
- Filing Date:
- 2011-02-28
- Accepted Time:
- 2011-02-28 14:25:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1451980 | Biocancell Therapeutics Inc. | BICL.TA | Pharmaceutical Preparations (2834) | 204630076 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1466920 | Hanoch Rappaport | C/O Biocancell Therapeutics, Inc. 8 Hartom St Jerusalem L3 97775 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-11-21 | 17,796 | $0.00 | 17,796 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The average purchase price was 2.84 NIS per share.
Billionaire Hedge Funds
